{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:55:40Z","timestamp":1791190540919,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.ijpharm.2012.12.033","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T03:03:51Z","timestamp":1357182231000},"page":"254-261","source":"Crossref","is-referenced-by-count":18,"title":["A new drug delivery system inhibits uveitis in an animal model after cataract surgery"],"prefix":"10.1016","volume":"443","author":[{"given":"Simone","family":"Eperon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rodriguez-Aller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Balaskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gurny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guex-Crosier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.12.033_bib0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00006982-200502000-00001","article-title":"The role of vascular endothelial growth factor in ocular health and disease","volume":"25","author":"Adamis","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0010","series-title":"Intraocular Drug Delivery","first-page":"265","article-title":"Intraocular sustained-release drug delivery in uveitis","author":"Cahill","year":"2006"},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0015","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/jps.21987","article-title":"A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases","volume":"99","author":"Choonara","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.icu.0000120711.35941.76","article-title":"Corticosteroids in posterior segment disease: an update on new delivery systems and new indications","volume":"15","author":"Ciulla","year":"2004","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0025","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7326\/0003-4819-117-7-578","article-title":"Renal function and blood pressure in patients receiving long-term, low-dose cyclosporine therapy for idiopathic autoimmune uveitis","volume":"117","author":"Deray","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0030","doi-asserted-by":"crossref","unstructured":"Eperon, S., Balaskas, K., Vaudaux, J.D., Guex-Crosier, Y. Experimental uveitis can be maintained in rabbits for a period of six weeks after a safe sensitization method. Curr. Eye Res., http:\/\/dx.doi.org\/10.3109\/02713683.2012.747616, in press.","DOI":"10.3109\/02713683.2012.747616"},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0035","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijpharm.2007.10.054","article-title":"A biodegradable drug delivery systems for the treatment of post-operative inflammation","volume":"352","author":"Eperon","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0040","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jcrs.2007.03.053","article-title":"Incidence of cataract surgery from 1980 through 2004: 25-year population-based study","volume":"33","author":"Erie","year":"2007","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0045","series-title":"Proceedings of the 5th International Symposium of Ocular Pharmacology and Therapeutics","first-page":"41","article-title":"Scleral implants \u2013 A potential route of administration?","author":"Felt-Baeyens","year":"2004"},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijpharm.2006.05.053","article-title":"Biodegradable scleral implants as new triamcinolone acetonide delivery systems","volume":"322","author":"Felt-Baeyens","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0055","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1167\/iovs.10-6071","article-title":"Sustained antibiotic release from an intraocular lens-hydrogel assembly for cataract surgery","volume":"52","author":"Garty","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0060","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1167\/iovs.10-5939","article-title":"Treatment of experimental anterior and intermediate uveitis by a dexamethasone intravitreal implant","volume":"52","author":"Ghosn","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0165-2427(00)00219-1","article-title":"Effect of an intravitreal cyclosporine implant on experimental uveitis in horses","volume":"76","author":"Gilger","year":"2000","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0070","series-title":"Principles and Practice of Ophthalmology, Vol. 1","first-page":"511","article-title":"Epidemiology of age-related cataract","author":"Hankinson","year":"2000"},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0075","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0039-6257(90)90068-7","article-title":"Cataract extraction in uveitis patients","volume":"35","author":"Hooper","year":"1990","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0080","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0161-6420(98)91176-9","article-title":"Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis","volume":"105","author":"Jaffe","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0085","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/17425247.4.4.371","article-title":"Novel approaches to retinal drug delivery","volume":"4","author":"Janoria","year":"2007","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0090","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ophtha.2004.10.042","article-title":"Intraocular pressure elevation after intravitreal triamcinolone acetonide injection","volume":"112","author":"Jonas","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0095","first-page":"650","article-title":"Intraocular penetration of topically applied cyclosporine","volume":"20","author":"Kaswan","year":"1988","journal-title":"Transplant Proc."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/11530970-000000000-00000","article-title":"Biodegradable intraocular therapies for retinal disorders: progress to date","volume":"27","author":"Kuno","year":"2010","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0105","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1136\/bjo.87.11.1424","article-title":"Surodex in paediatric cataract surgery","volume":"87","author":"Lee","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0110","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0115","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0896-1549(05)70264-9","article-title":"Postcataract cystoid macular edema","volume":"14","author":"Nagpal","year":"2001","journal-title":"Ophthalmol. Clin. North Am."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0002-9394(14)77814-6","article-title":"Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents","volume":"96","author":"Nussenblatt","year":"1983","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0125","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/jop.1985.1.369","article-title":"Cyclosporine therapy for uveitis: long-term followup","volume":"1","author":"Nussenblatt","year":"1985","journal-title":"J. Ocul. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0130","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1367-5931(00)00227-1","article-title":"Polymers in drug delivery","volume":"5","author":"Pillai","year":"2001","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0135","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ejpb.2011.11.017","article-title":"In vivo characterisation of a novel water-soluble cyclosporine A prodrug for the treatment of dry eye disease","volume":"80","author":"Rodriguez-Aller","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0140","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1167\/iovs.02-1228","article-title":"Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis","volume":"44","author":"Sakurai","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0145","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/ICU.0b013e32834bbd68","article-title":"Review and update of intraocular therapy in noninfectious uveitis","volume":"22","author":"Sallam","year":"2011","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0150","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1517\/13543784.2011.617741","article-title":"Road to remission: a comprehensive review of therapy in uveitis","volume":"20","author":"Siddique","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00055735-200102000-00011","article-title":"Effects of anti-inflammatory drugs following cataract extraction","volume":"12","author":"Simone","year":"2001","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0160","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1755-3768.2009.01536.x","article-title":"Functional and morphological changes in the eyes of Behcet's patients with uveitis","volume":"88","author":"Takeuchi","year":"2010","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0165","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/S0161-6420(01)00839-9","article-title":"Randomized clinical trial of Surodex steroid drug delivery system for cataract surgery: anterior versus posterior placement of two Surodex in the eye","volume":"108","author":"Tan","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/ICU.0b013e32834cd60e","article-title":"Postcataract surgical inflammation","volume":"23","author":"Taravati","year":"2012","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0175","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1167\/iovs.02-1112","article-title":"Pharmacokinetic and toxicity study of an intraocular cyclosporine DDS in the anterior segment of rabbit eyes","volume":"44","author":"Theng","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"Pt 3","key":"10.1016\/j.ijpharm.2012.12.033_bib0180","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/eye.1990.68","article-title":"Combination low dose cyclosporin A and steroid therapy in chronic intraocular inflammation","volume":"4","author":"Towler","year":"1990","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0185","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jcrs.2003.08.028","article-title":"Safety and efficacy of a dexamethasone anterior segment drug delivery system in patients after phacoemulsification","volume":"30","author":"Wadood","year":"2004","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9394(14)72840-5","article-title":"Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behcet's disease","volume":"118","author":"Whitcup","year":"1994","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.12.033_bib0195","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.addr.2005.09.005","article-title":"Intraocular sustained drug delivery using implantable polymeric devices","volume":"57","author":"Yasukawa","year":"2005","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312011052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312011052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T15:29:23Z","timestamp":1539962963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312011052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":39,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0378517312011052"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.12.033","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}